Compare FLNA & SLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FLNA | SLMT |
|---|---|---|
| Founded | 1998 | 2000 |
| Country | United States | Ireland |
| Employees | 20 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 68.9M |
| IPO Year | N/A | N/A |
| Metric | FLNA | SLMT |
|---|---|---|
| Price | $1.25 | $4.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 346.0K | 124.2K |
| Earning Date | 05-13-2026 | 06-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.16 | $0.56 |
| 52 Week High | $2.03 | $24.05 |
| Indicator | FLNA | SLMT |
|---|---|---|
| Relative Strength Index (RSI) | 40.61 | 54.44 |
| Support Level | $1.16 | $4.28 |
| Resistance Level | $1.80 | $6.86 |
| Average True Range (ATR) | 0.10 | 0.62 |
| MACD | -0.00 | -0.28 |
| Stochastic Oscillator | 4.41 | 6.39 |
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.